84 Schwelberger, H
The use the peptide Ac-Nle-c c/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH in the manufacture of a medicament for intranasal administration for use in the treatment of erectile dysfunction in a male, wherein the peptide Ac-Nle-cyc/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH increases cGMP levels to an amount sufficient to produce an erection sufficient for sexual intercourse when the peptide Ac-Nle-cyc/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH is administered at a sub-therapeutic dose and administered subsequent to a sub-therapeutic dose of a PDE-5 inhibitor
, 591 , 924-933, doi: Fan, D., Lin, X., Zhang, F., Zhong, W., Hu, J., Chen, Y., Cai, Z., Zou, Y., He, X., Chen, X., Lan, P., and Wu, X
About one in three participants achieved at least 20 percent weight loss
Bu rnt, srekli yksek bir seviye oluturmak yerine byme hormonu ekseninin fizyolojik pulsatilitesini taklit etmesi nedeniyle nemlidir